Related references
Note: Only part of the references are listed.The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision
Xiaojie Wang et al.
EJSO (2020)
Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer
Yuya Nakamura et al.
CANCER MEDICINE (2020)
Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Z. Zheng et al.
COLORECTAL DISEASE (2020)
Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer
Gota Saito et al.
ONCOLOGY (2018)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 22, 2017)
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2018)
Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy
Jun Lu et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer
Hisanori Miki et al.
DIGESTIVE SURGERY (2018)
Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis
Giuseppe Colloca et al.
MEDICAL ONCOLOGY (2017)
Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Y. Sun et al.
EJSO (2017)
A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center
Zhi-Fang Zheng et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis
Songmi Jeong et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study
Mi Joo Chung et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
American Joint Committee on Cancer and College of American Pathologists Regression Grade: A New Prognostic Factor in Rectal Cancer
Adam G. Mace et al.
DISEASES OF THE COLON & RECTUM (2015)
Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Lu-Ning Zhang et al.
MEDICINE (2015)
Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy
Hidenori Toyoda et al.
JOURNAL OF HEPATOLOGY (2012)
The Role of Carcinoembryonic Antigen After Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer
Na Young Jang et al.
DISEASES OF THE COLON & RECTUM (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
The Role of Carcinoembriogenic Antigen in Predicting Response and Survival to Neoadjuvant Chemoradiotherapy for Distal Rectal Cancer
Rodrigo O. Perez et al.
DISEASES OF THE COLON & RECTUM (2009)
CARCINOEMBRYONIC ANTIGEN AS A PREDICTOR OF PATHOLOGIC RESPONSE AND A PROGNOSTIC FACTOR IN LOCALLY ADVANCED RECTAL CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMORADIOTHERAPY AND SURGERY
Ji Won Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
The TME trial after a median follow-up of 6 years - Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
Koen C. M. J. Peeters et al.
ANNALS OF SURGERY (2007)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma
H Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer -: art. no. 62
D Azria et al.
BMC CANCER (2005)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Utility of tumor markers in determining resectability of pancreatic cancer
MG Schlieman et al.
ARCHIVES OF SURGERY (2003)
Prognostic value of p53 mutations in rectal carcinoma
C Rebischung et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
